Ge Healthcare Techs (GEHC) closed at $76.57 on October 30, 2026, up 0.2% from the previous close, on volume of 3,624,020 shares (30-day average 3,767,879).
Data as of October 30, 2026.
Nasdaq tanks 5% in October as tech bloodbath deepens
Seeking Alpha News (Fri, 30-Oct 4:54 PM ET)
TipRanks (Thu, 29-Oct 10:20 PM ET)
Midday Pulse: S&P 500 top intraday gainers
Seeking Alpha News (Thu, 29-Oct 12:05 PM ET)
GE Healthcare Technologies Inc (GEHC) Receives a Buy from Oppenheimer
TipRanks (Thu, 29-Oct 8:36 AM ET)
BMO Capital Reaffirms Their Hold Rating on GE Healthcare Technologies Inc (GEHC)
TipRanks (Thu, 29-Oct 8:11 AM ET)
GE Healthcare Technologies Inc (GEHC) Gets a Buy from RBC Capital
TipRanks (Thu, 29-Oct 7:31 AM ET)
TipRanks (Thu, 29-Oct 5:45 AM ET)
Barclays Remains a Buy on GE Healthcare Technologies Inc (GEHC)
TipRanks (Thu, 29-Oct 3:38 AM ET)
GE HealthCare rises after Q3 beat and guidance hike
Seeking Alpha News (Wed, 28-Oct 9:20 AM ET)
GE HealthCare raises 2026 outlook after 6.2% organic revenue growth and a 16.6% adjusted EBIT margin
Market Chameleon (Wed, 28-Oct 3:10 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of October 30, 2026, GEHC stock price climbed to $76.57 with 3,624,020 million shares trading.
GEHC has a beta of 0.68, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.06 to the broad based SPY ETF.
GEHC has a market cap of $34.59 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $159 million and exceeded earnings estimates by $.13.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, VOO, QQQ, VO, IVV.
GEHC has underperformed the market in the last year with a return of -0.9%, while SPY returned +11.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GEHC shares. However, GEHC has outperformed the market in the last 3 month and 2 week periods, returning +6.6% and +8.9%, while SPY returned +3.9% and -2.1%, respectively. This indicates GEHC has been having a stronger performance recently.
GEHC support price is $75.00 and resistance is $77.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.
